相似文献
1
Response to: Letter to the Editor regarding: The expanding phenotype of MELAS caused by the m.3291T > C tRNA mutation E. Kelland, C.A. Rupar, Asuri N. Prasad, A. Downie and C. Prasad (1) by Josef Finsterer, MD, PhD [1], Sinda Zarrouk-Mahjoub, PhD [2].
Mol Genet Metab Rep. 2016 Jun 1;7:96-7. doi: 10.1016/j.ymgmr.2016.05.001. eCollection 2016 Jun.
2
Response to: Letter to the Editor Regarding: The Expanding Phenotype of MELAS Caused by the m.3291 T > C tRNA Mutation E Kelland, C. A. Rupar, Asuri N. Prasad, K. Y. Tay, A. Downie and C. Prasad (1) by Josef Finsterer, MD, PhD [1], Sinda Zarrouk-Mahjoub, PhD [2] [1] Krankenanstalt Rudolfstiftung, Vienna [2] Genomics Platform, Pasteur Institute of Tunis, Tunisia.
Mol Genet Metab Rep. 2016 Jul 15;8:41-2. doi: 10.1016/j.ymgmr.2016.07.002. eCollection 2016 Sep.
3
Response of the authors to the comments of Josef Josef Finsterer and Sinda Zarrouk-Mahjoub on NeuroImage "Cerebral arterial and venous MRI abnormalities in MELAS".
Acta Neurol Belg. 2020 Apr;120(2):233. doi: 10.1007/s13760-018-0965-1. Epub 2018 Jun 11.
4
Reply to the letter to the editor by Josef Finsterer and Sinda Zarrouk-Mahjoub.
Brain Dev. 2018 May;40(5):444. doi: 10.1016/j.braindev.2018.02.006. Epub 2018 Mar 2.
5
The expanding phenotype of MELAS caused by the m.3291T > C mutation in the MT-TL1 gene.
Mol Genet Metab Rep. 2016 Feb 22;6:64-9. doi: 10.1016/j.ymgmr.2016.02.003. eCollection 2016 Mar.
6
Reply to the Letter to the Editor by Josef Finsterer and Sinda Zarrouk-Mahjoub.
Pediatr Neurol. 2018 Jan;78:e11. doi: 10.1016/j.pediatrneurol.2017.09.011. Epub 2017 Sep 21.
7
Response to the Letter to the Editor "The apparent beneficial effect of L-arginine for stroke-like lesions can be accidental" by Josef Finsterer and Sinda Zarrouk.
Neurohospitalist. 2022 Oct;12(4):715-720. doi: 10.1177/19418744221090276. Epub 2022 Jun 14.
8
Reply to 'Letter to Editor by Finsterer J and Zarrouk-Mahjoub S: Phenotypic manifestations of the m.8969G>A variant'.
Neurogenetics. 2018 May;19(2):133-134. doi: 10.1007/s10048-018-0542-z. Epub 2018 Feb 26.
9
Response to the Letter to the Editor by Finsterer and Zarrouk-Mahjoub in Clin Nephrol Case Stud. 2018; 6: 1.
Clin Nephrol Case Stud. 2018 Jan 16;6:2-3. doi: 10.5414/CNCS109366R. eCollection 2018.
10
Reply to the correspondence letter by J. Finsterer and S. Zarrouk-Mahjoub "Noncompaction in mitochondrial trifunctional protein deficiency due to a HADHB mutation".
Eur J Pediatr. 2015 Dec;174(12):1695. doi: 10.1007/s00431-015-2600-y. Epub 2015 Jul 31.
本文引用的文献
1
The expanding phenotype of MELAS caused by the m.3291T > C mutation in the MT-TL1 gene.
Mol Genet Metab Rep. 2016 Feb 22;6:64-9. doi: 10.1016/j.ymgmr.2016.02.003. eCollection 2016 Mar.
2
Cardiac manifestations of primary mitochondrial disorders.
Int J Cardiol. 2014 Dec 20;177(3):754-63. doi: 10.1016/j.ijcard.2014.11.014. Epub 2014 Nov 5.
3
Stroke and Stroke-like Episodes in Muscle Disease.
Open Neurol J. 2012;6:26-36. doi: 10.2174/1874205X01206010026. Epub 2012 May 18.
4
MERRF and Kearns-Sayre overlap syndrome due to the mitochondrial DNA m.3291T>C mutation.
Muscle Nerve. 2011 Sep;44(3):448-51. doi: 10.1002/mus.22149.
5
Molecular pathology of MELAS and L-arginine effects.
Biochim Biophys Acta. 2012 May;1820(5):608-14. doi: 10.1016/j.bbagen.2011.09.005. Epub 2011 Sep 14.
6
Topiramate and visual loss in a patient carrying a Leber hereditary optic neuropathy mutation.
Neurol Sci. 2012 Apr;33(2):419-21. doi: 10.1007/s10072-011-0755-5. Epub 2011 Sep 7.
Zotero 插件